Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenzhuo Recipe
- Development stage
- Preclinical
- Lead developer
- Guang'anmen Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shenzhuo Recipe is a Traditional Chinese Medicine (TCM) formulation currently under investigation for the treatment of diabetes kidney disease. It is specifically designed to address the 'qi deficiency and blood stasis syndrome' associated with the condition. The recipe is being studied in clinical trials, where it is administered in combination with standard basic treatment.
- Other names
- 中药肾浊方
02
Targets
HIF1A (Hypoxia-inducible factor 1-alpha)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Shenzhuo Recipe.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhuo Recipe.